Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)

Clinical trial NCT06391814 · COMPLETED

Trial details

NCT number: NCT06391814
Sponsor: Ciusss de L'Est de l'Île de Montréal
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

EBV Associated Lymphoma

Start date: 2024-01-16
Primary completion: 2025-04-05
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.